BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 2012; 18(1): 1-15 [PMID: 22228965 DOI: 10.3748/wjg.v18.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v18/i1/1.htm
Number Citing Articles
1
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future DirectionsSeminars in Liver Disease 2021; 41(03): 409 doi: 10.1055/s-0041-1730950
2
Ivo Graziadei. LebertransplantationWiener klinische Wochenschrift Education 2013; 8(2): 43 doi: 10.1007/s11812-013-0059-1
3
Andrea A. Gossard, Gregory J. Gores. Primary Sclerosing CholangitisClinics in Liver Disease 2017; 21(4): 725 doi: 10.1016/j.cld.2017.06.004
4
Andres F. Carrion, Kalyan Ram Bhamidimarri. Liver Transplant for Cholestatic Liver DiseasesClinics in Liver Disease 2013; 17(2): 345 doi: 10.1016/j.cld.2012.12.005
5
Michael Huw Chapman, Douglas Thorburn, Gideon M Hirschfield, George G J Webster, Simon M Rushbrook, Graeme Alexander, Jane Collier, Jessica K Dyson, David EJ Jones, Imran Patanwala, Collette Thain, Martine Walmsley, Stephen P Pereira. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitisGut 2019; 68(8): 1356 doi: 10.1136/gutjnl-2018-317993
6
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi. Transplantation of the Liver2015; : 1112 doi: 10.1016/B978-1-4557-0268-8.00084-1
7
Tatiana Hildebrand, Nadine Pannicke, Alexander Dechene, Daniel N. Gotthardt, Gabriele Kirchner, Florian P. Reiter, Martina Sterneck, Kerstin Herzer, Henrike Lenzen, Christian Rupp, Hannelore Barg-Hock, Philipp de Leuw, Andreas Teufel, Vincent Zimmer, Frank Lammert, Christoph Sarrazin, Ulrich Spengler, Christian Rust, Michael P. Manns, Christian P. Strassburg, Christoph Schramm, Tobias J. Weismüller. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysisLiver Transplantation 2016; 22(1): 42 doi: 10.1002/lt.24350
8
T. H. Karlsen, M. Vesterhus, K. M. Boberg. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitisAlimentary Pharmacology & Therapeutics 2014; 39(3): 282 doi: 10.1111/apt.12581
9
Siddharth Singh, Jayant A. Talwalkar. Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and ManagementClinical Gastroenterology and Hepatology 2013; 11(8): 898 doi: 10.1016/j.cgh.2013.02.016
10
Lina Lindström, Kristin K. Jørgensen, Kirsten M. Boberg, Maria Castedal, Allan Rasmussen, Andreas Arendtsen Rostved, Helena Isoniemi, Matteo Bottai, Annika Bergquist. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre StudyScandinavian Journal of Gastroenterology 2018; 53(3): 297 doi: 10.1080/00365521.2017.1421705
11
Fanni Gelley, Gergely Zádori, Dénes Görög, László Kóbori, Imre Fehérvári, György Gámán, Zsuzsanna Gerlei, Péter Nagy, Enikő Sárváry, Balázs Nemes. Recurrence of primary sclerosing cholangitis after liver transplantation — The Hungarian experienceInterventional Medicine and Applied Science 2014; 6(1): 16 doi: 10.1556/imas.6.2014.1.2
12
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Hiroto Egawa, Hideki Ohdan, Atsushi Yoshizawa, Norihiro Kokudo, Susumu Tazuma, Atsushi Tanaka, Hajime Takikawa. Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective studyTransplant International 2021; 34(5): 916 doi: 10.1111/tri.13852
13
Yang Shi, Shuqun Hu, Qingwei Song, Shengcai Yu, Xiaojun Zhou, Jun Yin, Lei Qin, Haixin Qian. Gene Silencing of 4-1BB by RNA Interference Inhibits Acute Rejection in Rats with Liver TransplantationBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/192738
14
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitisPathology International 2016; 66(7): 404 doi: 10.1111/pin.12427
15
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
16
A. J. Montano-Loza, R. A. Bhanji, S. Wasilenko, A. L. Mason. Systematic review: recurrent autoimmune liver diseases after liver transplantationAlimentary Pharmacology & Therapeutics 2017; 45(4): 485 doi: 10.1111/apt.13894
17
Ming-Li Yin, Hong-Li Song, Yang Yang, Wei-Ping Zheng, Tao Liu, Zhong-Yang Shen. Effect of <i>CXCR3/HO-1</i> genes modified bone marrow mesenchymal stem cells on small bowel transplant rejectionWorld Journal of Gastroenterology 2017; 23(22): 4016-4038 doi: 10.3748/wjg.v23.i22.4016
18
Christina W. Lee, Sean Ronnekleiv-Kelly. Autoimmune Diseases of the Biliary TractSurgical Clinics of North America 2019; 99(2): 185 doi: 10.1016/j.suc.2018.11.003
19
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBDCurrent Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
20
Wajeeh Salah, M. Edwyn Harrison. Practical Gastroenterology and Hepatology Board Review Toolkit2016; : 543 doi: 10.1002/9781119127437.ch86
21
EASL Clinical Practice Guidelines: Liver transplantationJournal of Hepatology 2016; 64(2): 433 doi: 10.1016/j.jhep.2015.10.006
22
Manuel Rodríguez-Perálvarez, Giacomo Germani, Vasilios Papastergiou, Emmanuel Tsochatzis, Evangelos Thalassinos, Tu Vinh Luong, Nancy Rolando, Amar Paul Dhillon, David Patch, James O’Beirne, Douglas Thorburn, Andrew Kenneth Burroughs. Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcomeJournal of Hepatology 2013; 58(2): 262 doi: 10.1016/j.jhep.2012.09.019
23
R.W. Chapman, K.D. Williamson. The Digestive Involvement in Systemic Autoimmune DiseasesHandbook of Systemic Autoimmune Diseases 2017; 13: 119 doi: 10.1016/B978-0-444-63707-9.00007-6
24
Ivo W. Graziadei. Recurrence of Nonviral Liver Diseases After Liver TransplantationClinics in Liver Disease 2014; 18(3): 675 doi: 10.1016/j.cld.2014.05.009
25
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experienceScandinavian Journal of Gastroenterology 2015; 50(6): 781 doi: 10.3109/00365521.2015.1028996
26
Mikio Zeniya, Masaki Iwai, Arief A. Suriawinata. Diagnosis of Liver Disease2019; : 97 doi: 10.1007/978-981-13-6806-6_9
27
Mette Vesterhus, Tom Hemming Karlsen. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunitiesJournal of Gastroenterology 2020; 55(6): 588 doi: 10.1007/s00535-020-01681-z
28
Denise M. Harnois, Kymberly D. S. Watt. Cholestatic Liver DiseaseClinical Gastroenterology 2014; : 189 doi: 10.1007/978-1-4939-1013-7_10
29
Konstantinos N. Lazaridis, Nicholas F. LaRusso. The CholangiopathiesMayo Clinic Proceedings 2015; 90(6): 791 doi: 10.1016/j.mayocp.2015.03.017
30
Johannes Klose, Michelle A. Klose, Courtney Metz, Frank Lehner, Michael P. Manns, Juergen Klempnauer, Nils Hoppe, Harald Schrem, Alexander Kaltenborn. Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease eraLangenbeck's Archives of Surgery 2014; 399(8): 1021 doi: 10.1007/s00423-014-1214-6
31
Ken Liu, Simone I. Strasser, David J. Koorey, Rupert W. Leong, Michael Solomon, Geoffrey W. McCaughan. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant settingExpert Review of Gastroenterology & Hepatology 2017; 11(10): 949 doi: 10.1080/17474124.2017.1343666
32
Aditi Kumar, Daniel Wheatley, Amar Puttanna. Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance ManagementClinical Medicine Insights: Gastroenterology 2016; 9: CGast.S38451 doi: 10.4137/CGast.S38451
33
Ertan Emek, Ayfer Serin, Tolga Sahin, Pinar Yazici, Yildiray Yuzer, Yaman Tokat, Birkan Bozkurt. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center ExperienceTransplantation Proceedings 2019; 51(7): 2439 doi: 10.1016/j.transproceed.2019.01.156
34
Neelam G Gidwaney, Swati Pawa, Kiron M Das. Pathogenesis and clinical spectrum of primary sclerosing cholangitisWorld Journal of Gastroenterology 2017; 23(14): 2459-2469 doi: 10.3748/wjg.v23.i14.2459
35
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2017; : 355 doi: 10.1007/978-3-319-07209-8_21
36
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive reviewJournal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
37
Nathalie A. Pena Polanco, Cynthia Levy, Eric F. Martin. Cholestatic Liver Diseases After Liver TransplantClinics in Liver Disease 2017; 21(2): 403 doi: 10.1016/j.cld.2016.12.011
38
Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationLiver Transplantation 2013; 19(1): 3 doi: 10.1002/lt.23566
39
Olalekan Lee Aiyegbusi, Fatima Isa, Derek Kyte, Tanya Pankhurst, Larissa Kerecuk, James Ferguson, Graham Lipkin, Melanie Calvert. Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative studyHealth and Quality of Life Outcomes 2020; 18(1) doi: 10.1186/s12955-020-01438-5
40
Kate D. Williamson, Roger W. Chapman. Primary sclerosing cholangitis: a clinical updateBritish Medical Bulletin 2015; 114(1): 53 doi: 10.1093/bmb/ldv019
41
Lauren A. Beste, Anne M. Larson. Primary Care of the Solid Organ Transplant Recipient2020; : 77 doi: 10.1007/978-3-030-50629-2_5
42
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse, Mark Hudson. Primary sclerosing cholangitisThe Lancet 2018; 391(10139): 2547 doi: 10.1016/S0140-6736(18)30300-3
43
Andrew L. Mason, Aldo J. Montano-Loza. Systematic investigation of elevated cholestatic enzymes during the third posttransplant monthLiver Transplantation 2013; 19(S2): S23 doi: 10.1002/lt.23742
44
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases2014; : 925 doi: 10.1016/B978-0-12-384929-8.00063-0
45
Bijan Eghtesad, John J. Fung. Pouchitis and Ileal Pouch Disorders2019; : 487 doi: 10.1016/B978-0-12-809402-0.00039-3
46
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1
47
Ali Reza Safarpour, Hassan Askari, Farshid Ejtehadi, Asaad Azarnezhad, Ehsan Raeis-Abdollahi, Amir Tajbakhsh, Mohammad Foad Abazari, Firoozeh Tarkesh, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Kamran Bagheri Lankarani, Fardad Ejtehadi. Cholangiocarcinoma and liver transplantation: What we know so far?World Journal of Gastrointestinal Pathophysiology 2021; 12(5): 84-105 doi: 10.4291/wjgp.v12.i5.84
48
Lukas Bajer, Antonij Slavcev, Peter Macinga, Eva Sticova, Jan Brezina, Matej Roder, Radim Janousek, Pavel Trunecka, Julius Spicak, Pavel Drastich. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with <i>de novo</i> inflammatory bowel diseaseWorld Journal of Gastroenterology 2018; 24(43): 4939-4949 doi: 10.3748/wjg.v24.i43.4939
49
Wenyi Chen, Jiaqi Zhu, Feiyan Lin, Yanping Xu, Bing Feng, Xudong Feng, Xinyu Sheng, Xiaowei Shi, Qiaoling Pan, Jinfeng Yang, Jiong Yu, Lanjuan Li, Hongcui Cao. Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioidsStem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02271-3
50
Frank Schmitz. MR-Cholangiographie bringt Licht ins Dunkel der PSC bei chronisch-entzündlicher DarmerkrankungDer Gastroenterologe 2016; 11(6): 495 doi: 10.1007/s11377-016-0119-z
51
Adam VanHuis, Veronica Loy. Myth: Liver Transplant Provides a Cure for Liver DiseaseClinical Liver Disease 2019; 13(6): 154 doi: 10.1002/cld.770
52
Siddharth Singh, Edward V Loftus, Jayant A Talwalkar. Inflammatory Bowel Disease after Liver Transplantation for Primary Sclerosing CholangitisAmerican Journal of Gastroenterology 2013; 108(9): 1417 doi: 10.1038/ajg.2013.163
53
Chaoran Zhang, Trana Hussaini, Eric M Yoshida. Review of pharmacotherapeutic treatments for primary sclerosing cholangitisCanadian Liver Journal 2019; 2(3): 58 doi: 10.3138/canlivj-2018-0016
54
René P. Michel, Victoria A. Marcus. Pathology of Transplantation2016; : 173 doi: 10.1007/978-3-319-29683-8_6
55
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativaIatreia 2020; 33(3): 251 doi: 10.17533/udea.iatreia.57
56
Lydia M. Petrovic. Recurrent diseases following liver transplantationCurrent Opinion in Organ Transplantation 2012; 17(3): 293 doi: 10.1097/MOT.0b013e32835365f6
57
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System2018; : 341 doi: 10.1002/9781119237662.ch18
58
Yan-Hua Lai, Wei-Dong Duan, Qiang Yu, Sheng Ye, Nian-Jun Xiao, Dong-Xin Zhang, Zhi-Qiang Huang, Zhan-Yu Yang, Jia-Hong Dong. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver diseaseWorld Journal of Gastroenterology 2015; 21(20): 6296-6303 doi: 10.3748/wjg.v21.i20.6296
59
Veena L Venkat, Sarangarajan Ranganathan, Rakesh Sindhi. The challenges of liver transplantation in children with primary sclerosing cholangitisExpert Review of Gastroenterology & Hepatology 2015; 9(3): 289 doi: 10.1586/17474124.2015.1002085
60
Melinda J. Yeh, So Yeon Kim, Kartik S. Jhaveri, Spencer C. Behr, Nieun Seo, Benjamin M. Yeh. Imaging of autoimmune biliary diseaseAbdominal Radiology 2017; 42(1): 3 doi: 10.1007/s00261-016-0903-8
61
Palak J. Trivedi, Irene Scalera, Emma Slaney, Richard W. Laing, Bridget Gunson, Gideon M. Hirschfield, Andrea Schlegel, James Ferguson, Paolo Muiesan. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitisJournal of Hepatology 2017; 67(5): 957 doi: 10.1016/j.jhep.2017.06.027
62
Varun Saxena, Norah A. Terrault. Zakim and Boyer's Hepatology2018; : 784 doi: 10.1016/B978-0-323-37591-7.00053-7
63
Dorothee Schwinge, Christoph Schramm. Sex-related factors in autoimmune liver diseasesSeminars in Immunopathology 2019; 41(2): 165 doi: 10.1007/s00281-018-0715-8
64
Keith D Lindor, Kris V Kowdley, Edwyn M Harrison. ACG Clinical Guideline: Primary Sclerosing CholangitisAmerican Journal of Gastroenterology 2015; 110(5): 646 doi: 10.1038/ajg.2015.112
65
Trygve Thorsen, Einar Martin Aandahl, William Bennet, Michael Olausson, Bo-Göran Ericzon, Greg Nowak, Frans Duraj, Helena Isoniemi, Allan Rasmussen, Tom H. Karlsen, Aksel Foss. Transplantation With Livers From Deceased Donors Older Than 75 YearsTransplantation 2015; 99(12): 2534 doi: 10.1097/TP.0000000000000728
66
Tom H. Karlsen, Kirsten Muri Boberg. Update on primary sclerosing cholangitisJournal of Hepatology 2013; 59(3): 571 doi: 10.1016/j.jhep.2013.03.015
67
Marie Irlès‐Depé, Stéphanie Roullet, Martine Neau‐Cransac, Jérôme Dumortier, Sébastien Dharancy, Pauline Houssel‐Debry, Olivier Boillot, Laurence Chiche, Christophe Laurent, David Laharie, Victor De Lédinghen. Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing CholangitisLiver Transplantation 2020; 26(11): 1477 doi: 10.1002/lt.25838
68
Jonathan Merola, Robert M. Mocharla, Alexander Z. Jow, Samuel H. Sigal, Amar Safdar. Principles and Practice of Transplant Infectious Diseases2019; : 303 doi: 10.1007/978-1-4939-9034-4_17
69
Harald Hofer, Emina Halilbasic, Katharina Staufer, Michael Trauner. Liver Immunology2014; : 301 doi: 10.1007/978-3-319-02096-9_20
70
Sanjaya K. Satapathy, Ollie D. Jones, Jason M. Vanatta, Faisal Kamal, Satish K. Kedia, Yu Jiang, Satheesh P. Nair, James D. Eason. Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without CorticosteroidTransplantation Direct 2017; 3(7): e178 doi: 10.1097/TXD.0000000000000693
71
Brian K. Chung, Tom Hemming Karlsen, Trine Folseraas. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1390 doi: 10.1016/j.bbadis.2017.08.020
72
Michael R. Lucey. Liver Transplantation2013; : 290 doi: 10.1002/9781118675915.ch26
73
David Choi, Mengyuan Liu, Dharani Guttikonda, Kelly Galen, Grace Guzman, Hoonbae Jeon, Costica Aloman. Recipient risk factors for acute cellular rejection after orthotopic liver transplant ‐ a single‐center, retrospective studyTransplant International 2020; 33(12): 1779 doi: 10.1111/tri.13756
74
Nabiha Faisal, Eberhard L Renner. Recurrence of autoimmune liver diseases after liver transplantationWorld Journal of Hepatology 2015; 7(29): 2896-2905 doi: 10.4254/wjh.v7.i29.2896
75
Michael E. Sutton, Rico D. Bense, Ton Lisman, Eric J. van der Jagt, Aad P. van den Berg, Robert J. Porte. Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomyLiver Transplantation 2014; 20(4): 457 doi: 10.1002/lt.23827
76
Julie R. Ingelfinger, Konstantinos N. Lazaridis, Nicholas F. LaRusso. Primary Sclerosing CholangitisNew England Journal of Medicine 2016; 375(12): 1161 doi: 10.1056/NEJMra1506330
77
John E. Eaton, Jayant A. Talwalkar, Konstantinos N. Lazaridis, Gregory J. Gores, Keith D. Lindor. Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and ManagementGastroenterology 2013; 145(3): 521 doi: 10.1053/j.gastro.2013.06.052
78
Shishir Shetty, David H Adams, Stefan G Hubscher. Post-transplant liver biopsy and the immune response: lessons for the clinicianExpert Review of Clinical Immunology 2012; 8(7): 645 doi: 10.1586/eci.12.65
79
Christopher L. Bowlus. Liver Immunology2020; : 395 doi: 10.1007/978-3-030-51709-0_25